Category

BioTalk

Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, Joins Rich Bendis on BioTalk

By | BioTalk, News | No Comments

Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, joins BioTalk to discuss her career, the economic development environment in Baltimore, and how to create a greater sense of partnership between perceived competing regions.

Listen now via Apple https://apple.co/2DikZfg, Google https://bit.ly/2Exq5oD , Spotify https://spoti.fi/31GmIUV, TuneIn https://bit.ly/32FjGQ5, and YouTube Audio https://bit.ly/31IwGFl.

Michele L. Whelley, President & CEO, is an economic development professional who is well-known throughout the region’s business community, Whelley brings new energy and focus to marketing the region, ensuring that EAGB will continue to strengthen its marketing platform as a critical component of fostering and supporting a vibrant and growing economy throughout the Greater Baltimore region.
Whelley’s diverse career as an economic development leader includes serving as the CEO of the Central Maryland Transportation Alliance, as the founding CEO of the Economic Development Corporation of New Haven, CEO of the Downtown Partnership of Baltimore and executive vice-president of the Baltimore Development Corporation.  Additionally, she has provided consulting services for Johns Hopkins Medical Institutions, several private sector development companies and staffed an economic development practice at Colliers Pinkard, a real estate brokerage company. More recently, Whelley has provided a full range of economic development consulting services to organizations including Howard Hughes Corporation, Baltimore Integration Partnership, Southern Management Corporation, Network Rail Consulting, Inc., and Betamore.

Whelley received both her Bachelor of Arts and Master of Arts from the University of Maryland. She then attended the University of Maryland School of Law where she received her Juris Doctor. She sits on the board of directors for The Hippodrome Foundation, Baltimore Design School and Downtown Partnership of Baltimore.

Jennifer Butler, Executive Vice President and General Manager, Innate Pharma US Inc. sits down with Rich Bendis for BioTalk

By | BioTalk, News | No Comments

Jennifer Butler, Executive Vice President and General Manager, Innate Pharma US Inc. joins Rich Bendis on BioTalk to discuss her career, bringing Innate from France to the US, and goals.

Listen now on Apple https://apple.co/3i30Bxs, Google https://bit.ly/2PkUw2U, Spotify https://spoti.fi/31gDh8n, TuneIn https://bit.ly/3fqn7i3, and YouTube Audio https://bit.ly/3kgU9ou.

Jennifer Butler was appointed Executive Vice President and General Manager of Innate Pharma US Inc. in March 2019.

Prior to her appointment, Ms. Butler served as Chief Business Officer, Chief Commercial Officer and Head of US operations, responsible for global business development and commercial strategy at Tessa Therapeutics, a clinical-stage oncology company. She previously served for more than 10 years in various commercial and strategy roles with increasing responsibility at AstraZeneca/MedImmune across several therapeutic areas. Ms. Butler also previously worked in strategic healthcare consulting and as an analyst in Equity Capital Markets at Merrill Lynch.

Ms. Butler has more than 20 years of strategic marketing and commercial leadership expertise along with general management experience.

Click Here to Read the Transcript.

BioFactura, Inc. Co-Founder, President & CEO, Darryl Sampey, PH.D., Virtually Sits Down with Rich Bendis for BioTalk

By | BioTalk, News | No Comments

BioFactura, Inc. Co-Founder, President & CEO, Darryl Sampey, PH.D., joins BioTalk to discuss his background with the University of Maryland, the BioHealth Capital Region, and the creation of his company in Frederick.

Listen now via Google https://bit.ly/3hz2jpU, Apple https://apple.co/3eYLiUs, Spotify https://spoti.fi/3f3cqBU, TuneIn https://bit.ly/302voUG, and YouTube (Audio Only) https://bit.ly/3f3cQZ0

Darryl Sampey co-founded BioFactura in 2004 and has guided the venture over the past 15 years from start-up through incubator stages to become a significant biopharmaceutical product development and clinical manufacturing company. As President and CEO, Dr. Sampey manages all strategic and scientific endeavors of the Company. Before BioFactura, he led both process development and manufacturing teams at Human Genome Sciences, Inc. (HGS) honing his skills developing and scaling up new biologics processes and control strategies. During his tenure with HGS, Dr. Sampey played key roles in the start-up, commissioning, and validation of the company’s first cGMP manufacturing facility and associated development laboratories. Prior to his work at HGS, Dr. Sampey gained industrial experience in the commercial research laboratory designing and optimizing fermentation and product recovery processes for novel vaccines at North American Vaccine, Inc. His work in vaccine research has since progressed to internationally-approved vaccines for whooping cough in infants and meningitis in adults. Darryl Sampey began his career in biotechnology at the University of Maryland graduating first in his class with a Bachelor of Science in Chemical Engineering, Magna Cum Laude, and, subsequently earned a Ph.D. in Bioengineering.

Alex Philippidis, Genetic Engineering and Biotechnology News Senior News Editor, Guests on BioTalk

By | BioTalk, News | No Comments

Alex Philippidis joins Rich Bendis on BioTalk to discuss the BioHealth Capital Region from a National viewpoint, other Hubs, and how the industry has adapted in the age of COVID-19.

Alex specializes in biopharma business news and industry issues for GEN. He joined GEN in 2011 after four years at GenomeWeb, where he covered research institutes and spent three years following biotech economic development as editor of the weekly newsletter BioRegion News. Alex reports a variety of news stories for GEN and Clinical OMICs and compiles the popular A-Lists series.

Alex previously worked for more than 20 years for various newspapers covering business, science, the Navy, and general-interest news. He has been interviewed and quoted by news outlets, including the New York Times and the BBC. He enjoys solving crossword puzzles, watching classic TV game shows, and traveling with his family.

Listen now on Google https://bit.ly/2Zj6Jd8, Apple https://apple.co/3eMbNNu, Spotify https://spoti.fi/389Jk1Chttps://bit.ly/38d32K3, and YouTube (audio) https://bit.ly/31tr16m.

Click here to view the transcript.

Charles Andres and Christian Barrow join BioTalk to discuss investing, growth and the BioHealth Capital Region during COVID-19

By | BioTalk, News | No Comments

Charles Andres, Ph.D., RAC, Associate at Wilson Sonsini Goodrich & Rosati, and Christian Barrow, Executive Director, Life Sciences Banking at JP Morgan, join Rich Bendis for a Virtual BioTalk

Charles Andres, Ph.D., RAC, is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati. He focuses on patent prosecution, strategic patent counseling, IP due diligence, drug and medical device FDA regulatory counseling, invalidity and non-infringement opinions, life-cycle management, Supreme Court and Federal Circuit amicus briefs, and related business matters.

Charlie has significant experience drafting patent applications, prosecuting patent applications in the U.S. and abroad, and evaluating the claims of issued patents. He has won cases before the Board of Patent Appeals and Interferences by brief and on oral argument. Patents Charlie has obtained have been listed in the Orange Book and asserted against a generic pharmaceutical manufacturer, and he has drafted and filed multiple applications for patent term extension. Companies he has obtained patents for have been sold for a cumulative total of approximately $4 billion.

Christian Barrow is a senior banker with J. P. Morgan commercial bank. Chris joined J.P. Morgan in 2012 in the Philadelphia office, where he and his team focus on providing financial solutions to life sciences companies located in the Mid-Atlantic – Delaware, Pennsylvania, and Maryland. Chris has over 25 years of experience in the financial services industry with roles that have spanned from public accounting to banking.

Chris’ current job is to help life science companies in biotech, specialty pharmaceutical, specialty pharmacy, medical device, med-tech, medical diagnostics, and contract research organizations, gain access to JPMorgan’s well-known healthcare commercial and investment banking resources.

Prior to his current role, Chris started his career with EY (inactive CA and CPA licenses). He subsequently served as a senior banker for Bank of America. In this capacity, he was responsible for origination and structuring of debt products to general industry companies located in Pennsylvania.

Chris holds a bachelor’s degree in Biology and a graduate diploma in Accounting both from McGill University. He currently resides in Doylestown, Pennsylvania with his wife and two children.

Listen now via Apple https://apple.co/2Z4yyWC, Google https://bit.ly/2AYElou, Spotify https://spoti.fi/3eqnfhR, TuneIn https://bit.ly/3fM8N3R, and audio via YouTube https://bit.ly/3fMmvnj

Emergent BioSolutions Executive Vice President, Manufacturing and Technical Operations, Sean Kirk Guests on BioTalk

By | BioTalk, News | No Comments

Sean M. Kirk, Executive Vice President, Manufacturing and Technical Operations at Emergent BioSolutions joins Rich Bendis to discuss the COVID-19 Health Crisis, Emergent’s Capabilities in Manufacturing in the BioHealth Capital Region and Beyond

 

Listen now via Apple Podcasts (https://apple.co/3aDYSLz), Google Podcasts (https://bit.ly/2Uzh5o6), Spotify (https://spoti.fi/3bIzTqt), and TuneIn (https://bit.ly/3bOKSyV)

 

Mr. Kirk joined Emergent BioSolutions in 2003 and has served as executive vice president, manufacturing and technical operations since April 2019. Prior to this position, Mr. Kirk has held various senior leadership roles including senior vice president, manufacturing operations and contract development and manufacturing operations (CDMO) business unit lead from April 2017 to March 2019, senior vice president, biodefense operations from November 2015 to March 2017, senior vice president, biosciences operations from February 2014 to November 2015 and senior vice president, biodefense vaccines and therapeutics development from March 2012 to February 2014. Mr. Kirk also served in multiple roles of increasing responsibility at Emergent’s manufacturing operations site in Lansing, Michigan.

 

Before joining Emergent, Mr. Kirk worked at Merial, a multinational animal health company, serving in various positions from 1996 to 2001. Mr. Kirk received both an M.B.A. and B.S. in Microbiology from the University of Georgia.

Stewart L. Edelstein, Ph.D., Executive Director of the Universities at Shady Grove, Joins Rich Bendis on BioTalk

By | BioTalk, News | No Comments

Executive Director of the Universities at Shady Grove, Stewart L. Edelstein, Ph.D., joins BioTalk to discuss his career, USG, and its role in the BioHealth Capital Region

Dr. Stewart Edelstein joined the Universities at Shady Grove (USG) as Executive Director in 2002 and in 2007 was named to the dual title of Associate Vice Chancellor for Academic Affairs for the University System of Maryland (USM).

USG is a regional campus of USM that offers both undergraduate and graduate degree programs from nine partner universities. During Dr. Edelstein’s tenure, USG expanded its number of participating universities, as well as the breadth and depth of its academic programs, and enrollment has grown significantly, to more than 3,000 students. The campus’s capacity for future enrollment growth has doubled with the recent opening of a new Biomedical Sciences and Engineering Education Facility, which is expanding degree and certification offerings in healthcare, engineering, biosciences, computer science and other areas.

Under Dr. Edelstein’s leadership, USG has collaborated with Montgomery College and Montgomery County Public Schools (MCPS) to better articulate curriculum planning and degree completion initiatives within the county. An important partnership is a series of 2+2+2 programs – together with MCPS and MC – to create education and career pathways in professional fields. These initiatives place special emphasis on strengthening the pipeline for underrepresented and first-generation college student populations.

Dr. Edelstein serves on the Montgomery County Chamber of Commerce’s board of directors and as co-chair of its Economic Development Committee. He is on the board of Identity, WorkSource Montgomery, and Montgomery Moving Forward, and on the Maryland Cybersecurity Council. He served as a member of the Montgomery County Bioscience Task Force, the Montgomery County Smart Growth Initiative, and the Montgomery County Life Sciences Advisory Committee. He has been honored for his many contributions to the community by the Montgomery County Chamber, the Montgomery County Board of Education, and by the County Executive’s Hispanic Gala.

Prior to arriving at USG, Dr. Edelstein enjoyed a 25-year career at the University of Maryland, College Park, where he ultimately served as Senior Associate Dean of the College of Behavioral and Social Sciences. Dr. Edelstein received his bachelor’s degree from the State University of New York at Buffalo and his master’s degree and Ph.D. from the University of California at Berkeley.

Listen now on Google http://bit.ly/2QjAvL4, Apple https://apple.co/2U7Mexv, Spotify https://spoti.fi/38Rge5R, and TuneIn http://bit.ly/2wee42W

Click here to view the transcript.

Chris Frew, Founder of BioBuzz and Workforce Genetics, Joins Rich Bendis on BioTalk

By | BioTalk, News | No Comments

BioBuzz and Workforce Genetics Founder, Chris Frew, Joins BioTalk to discuss building two organizations, talent acquisition, and his role in the BioHealth Capital Region

Chris is the Founder and CEO of Workforce Genetics, LLC (WGx), and BioBuzz Media to foster highly engaging experiences that connect people and companies across biohealth ecosystems. His insights into talent attraction, employer branding, and marketing have helped top companies to tackle their most pressing challenges in the new talent economy. Previously as Vice President at Breezio, a leading innovator in cloud-based online communities, he lead the development of the new Internship Network of Maryland (inMD) platform that was approved by Gov. Hogan in 2017. As Vice President of Tech USA’s Scientific Division Chris founded and ran a national staffing division operating at $23M annually when he left in 2015. Chris is passionate about impacting others, especially his family and his team, and helping to foster a strong community within the BioHealth Capital Region. He is a Maryland native and a graduate of Towson University. Learn more at https://www.workforcegenetics.com/ and http://biobuzz.io/

Listen now on Apple https://apple.co/39DicIl, Google http://bit.ly/2Q0e1id, Spotify https://spoti.fi/3aDIOZL, and TuneIn http://bit.ly/2TJr4Fu.

Click Here to Download the Transcript 

BHI Managing Director, Economic Development, Judy Costello joins BioTalk to discuss her Career, BioHealth Innovation, and the BioHealth Capital Region

By | BioTalk, News | No Comments

Judy Costello is the Managing Director of Economic Development for BioHealth Innovation, Inc. (BHI). A longtime supporter of the region’s entrepreneur and start-up communities, Judy Costello joined BioHealth Innovation in August 2017. Prior to that she served as Director of the Maryland Department of Commerce’s Office of BioHealth and Life Sciences and Deputy Director of the department’s BioMaryland Center. She previously worked for fifteen years for the Business Alliance organizing venture pitch forums, entrepreneur bootcamps, tech transfer showcases, educational seminars, and other programs connecting entrepreneurs, faculty innovators, students, and industry leaders in Maryland, DC and Virginia with each other and with those providing funding and other resources to young companies.

Listen now on Apple (https://apple.co/32oVlh6), Google (http://bit.ly/32kjUvx), Spotify (https://spoti.fi/38VP3HZ), and TuneIn (http://bit.ly/32mOuo8)

Click here to download the PDF Transcript

Chuck Morton, Partner, Venable, LLP, guests on BioTalk

By | BioTalk, News | No Comments

Chuck Morton, Partner, Venable, LLP, joins BioTalk host Rich Bendis to discuss the local entrepreneurial and business ecosystem, regionalism, and the BioHealth Capital Region

Chuck Morton is co-chair of Venable’s Corporate Group. Chuck is recognized for his abilities in guiding financing, mergers and acquisitions (M&A), and other transactions involving middle-market companies. Chuck assists lenders, investors, and entrepreneurs as they create, build, and buy or sell businesses, primarily in the healthcare, technology, and consumer products industries. He regularly acts on behalf of private equity groups and banks. Chuck currently serves as the Secretary on the BioHealth Innovation Board of Directors.

Listen now on Apple Podcasts https://apple.co/2QwoEIl, Google Podcasts http://bit.ly/33sWjJc, and TuneIn http://bit.ly/2M60Wmx

Join our Mailing List